Clinical Trial Update: Clinical Trial of Growth Hormone in MPS I, II, and VI [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating growth hormone for Mucopolysaccharidosis I and II (Phase 2/Phase 3) was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis
• Mucopolysaccharidosis Ii

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Mucopolysaccharidosis I, Mucopolysaccharidosis II | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2014-11-24